SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in BFRI — Biofrontera Inc.
CIK 1446194
BALA CYNWYD, PA
Position in BFRI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$31,206
+$24,625 QoQ
Shares Held
84,378
+40.5% QoQ
Ownership
0.568%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BFRI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $270,934,979 across 52 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
1,504,358 | $108,103,165 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
88,579 | $47,994,759 | |
| 3 | LQDA |
Liquidia Corp
|
471,067 | $37,558,171 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,195,651 | $11,956,510 | |
| 5 | PRGO |
PERRIGO Co plc
|
1,149,496 | $11,943,263 | |
| 6 | HROW |
Harrow, Inc.
|
190,116 | $8,074,226 | |
| 7 | VTRS |
Viatris Inc
|
295,261 | $4,688,744 | |
| 8 | TLRY |
Tilray Brands, Inc.
|
1,021,777 | $4,587,778 |
All Filings in BFRI
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,206 | 38,574 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $6,581 | 11,546 | Shares | Other | 2026-02-17 | |
| 2021-12-31 | $383,595 | 51,010 | Shares | Defined | 2022-04-05 | |
| No filing history on record for this holder in this stock. | ||||||